Ümit Yaşar

2.9k total citations
71 papers, 2.3k citations indexed

About

Ümit Yaşar is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Ümit Yaşar has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pharmacology, 21 papers in Oncology and 16 papers in Pharmacology. Recurrent topics in Ümit Yaşar's work include Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (15 papers) and Inflammatory mediators and NSAID effects (10 papers). Ümit Yaşar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (15 papers) and Inflammatory mediators and NSAID effects (10 papers). Ümit Yaşar collaborates with scholars based in Türkiye, Sweden and United States. Ümit Yaşar's co-authors include Erik Eliasson, Magnus Ingelman‐Sundberg, Marja­‐Liisa Dahl, Anders Rane, Gunnel Tybring, Folke Sjöqvist, Atilla Bozkurt, Marja-Liisa Dahl, Melih O. Babaoğlu and Moustapha Hassan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Ümit Yaşar

69 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ümit Yaşar Türkiye 25 1.5k 800 433 389 363 71 2.3k
A. Mahgoub United Kingdom 10 1.2k 0.8× 551 0.7× 178 0.4× 443 1.1× 90 0.2× 12 1.8k
Joyce Blaisdell United States 30 2.8k 1.9× 1.6k 2.0× 651 1.5× 908 2.3× 589 1.6× 35 4.4k
Robert L. Walsky United States 25 1.8k 1.2× 927 1.2× 318 0.7× 666 1.7× 176 0.5× 35 2.7k
Sonia M. F. de Morais United States 11 1.0k 0.7× 506 0.6× 207 0.5× 342 0.9× 133 0.4× 11 1.5k
Aleksi Tornio Finland 25 883 0.6× 615 0.8× 310 0.7× 295 0.8× 140 0.4× 68 1.9k
Mahfoud Assem United States 22 1.5k 1.0× 1.4k 1.7× 122 0.3× 851 2.2× 130 0.4× 33 3.2k
Kenji Otsubo Japan 31 1.2k 0.8× 1.8k 2.3× 358 0.8× 812 2.1× 245 0.7× 71 3.9k
Jean-Pierre Flinois France 21 805 0.6× 433 0.5× 98 0.2× 405 1.0× 178 0.5× 31 1.4k
Jin‐ding Huang Taiwan 21 1.0k 0.7× 779 1.0× 210 0.5× 468 1.2× 113 0.3× 61 1.9k
John A. Pieper United States 25 951 0.7× 531 0.7× 391 0.9× 256 0.7× 174 0.5× 65 1.9k

Countries citing papers authored by Ümit Yaşar

Since Specialization
Citations

This map shows the geographic impact of Ümit Yaşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ümit Yaşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ümit Yaşar more than expected).

Fields of papers citing papers by Ümit Yaşar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ümit Yaşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ümit Yaşar. The network helps show where Ümit Yaşar may publish in the future.

Co-authorship network of co-authors of Ümit Yaşar

This figure shows the co-authorship network connecting the top 25 collaborators of Ümit Yaşar. A scholar is included among the top collaborators of Ümit Yaşar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ümit Yaşar. Ümit Yaşar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yaşar, Ümit. (2018). The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Central European Journal of Immunology. 43(2). 220–221. 1 indexed citations
2.
Kılıç, Levent, Ali Akdoğan, Melih O. Babaoğlu, et al.. (2015). Lower CYP2C9 activity in Turkish patients with Behçet’s disease compared to healthy subjects: a down-regulation due to inflammation?. European Journal of Clinical Pharmacology. 71(10). 1223–1228. 10 indexed citations
3.
Gündoğdu, Haldun, et al.. (2013). Is a routine preoperative rectosigmoidoscopy necessary in patients with bilateral inguinal hernia?. Bratislavské lekárske listy/Bratislava medical journal. 113(10). 604–606. 1 indexed citations
4.
Asena, Leyla, Yonca A. Akova, Atilla Bozkurt, et al.. (2013). Ocular Pharmacokinetics, Safety and Efficacy of Intracameral Moxifloxacin 0.5% Solution in a Rabbit Model. Current Eye Research. 38(4). 472–479. 17 indexed citations
5.
Atilla, Pergin, et al.. (2012). The therapeutic effects of melatonin and nimodipine in rats after cerebral cortical injury. Turkish Neurosurgery. 22(6). 740–6. 5 indexed citations
6.
Güngör, Sirel Gür, Yonca A. Akova, Atilla Bozkurt, et al.. (2010). Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. British Journal of Ophthalmology. 95(9). 1272–1275. 10 indexed citations
7.
Yaşar, Ümit, et al.. (2009). Kanıta Dayalı Tıp: Kavramlar, Örnekler ve Görüşler. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(5). 1298–1305.
8.
Yaşar, Ümit, Melih O. Babaoğlu, & Atilla Bozkurt. (2008). Disposition of a CYP2C9 Phenotyping Agent, Losartan, Is Not Influenced by the Common 3435C > T Variation of the Drug Transporter Gene ABCB1 (MDR1). Basic & Clinical Pharmacology & Toxicology. 103(2). 176–179. 8 indexed citations
9.
Ünal, Şule, Benan Bayrakçı, Ümit Yaşar, & Tevfik Karagöz. (2007). Successful Treatment of Propafenone, Digoxin and Warfarin Overdosage with Plasma Exchange Therapy and Rifampicin. Clinical Drug Investigation. 27(7). 505–508. 19 indexed citations
10.
Yaşar, Ümit, et al.. (2006). Tamoxifen Inhibits Cytochrome P450 2C9 Activity in Breast Cancer Patients. Journal of Chemotherapy. 18(4). 421–424. 18 indexed citations
11.
Gunes, Arzu, Uğur Çoşkun, Nazan Günel, et al.. (2006). Inhibitory Effect of 5‐Fluorouracil on Cytochrome P450 2C9 Activity in Cancer Patients. Basic & Clinical Pharmacology & Toxicology. 98(2). 197–200. 30 indexed citations
12.
Yaşar, Ümit, et al.. (2006). Variant alleles and genotypes of alcohol dehydrogenase 3 in aTurkish population. Methods and Findings in Experimental and Clinical Pharmacology. 28(4). 229–229. 3 indexed citations
13.
Xie, Hong, Parvaneh Afsharian, Ylva Terelius, et al.. (2005). Cyclophosphamide induces mRNA, protein and enzyme activity of cytochrome P450 in rat. Xenobiotica. 35(3). 239–251. 15 indexed citations
14.
Griškevičius, Laimonas, Ümit Yaşar, Mia Sandberg, et al.. (2003). Bioactivation of cyclophosphamide: the role of polymorphic CYP2C enzymes. European Journal of Clinical Pharmacology. 59(2). 103–109. 61 indexed citations
15.
Yaşar, Ümit, et al.. (2003). Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation. The Pharmacogenomics Journal. 3(1). 53–61. 180 indexed citations
16.
Yaşar, Ümit, et al.. (2002). Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk. (Letter to the Editor). Carcinogenesis. 23. 665. 1 indexed citations
17.
Batman, Coşar, Ümit Yaşar, Yüksel Totan, et al.. (1999). Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid. British Journal of Ophthalmology. 83(10). 1183–1185. 8 indexed citations
18.
Çekıç, Osman, Coşar Batman, Yüksel Totan, et al.. (1999). Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye. 13(5). 656–659. 15 indexed citations
19.
Çekıç, Osman, et al.. (1998). PENETRATION OF OFLOXACIN IN HUMAN AQUEOUS AND VITREOUS HUMORS FOLLOWING ORAL AND TOPICAL ADMINISTRATION. Retina. 18(6). 521–525. 28 indexed citations
20.
Erdem, Remzi, Ümit Yaşar, & Meral Tuncer. (1998). The Possible Role of Endothelin(s) in Cyclosporine A Preparations—Induced Contraction of Guinea Pig Isolated Gallbladder Strips. General Pharmacology The Vascular System. 31(4). 607–611. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Mahgoub Breakdown of academic impact, for papers by Joyce Blaisdell Breakdown of academic impact, for papers by Robert L. Walsky Breakdown of academic impact, for papers by Sonia M. F. de Morais Breakdown of academic impact, for papers by Aleksi Tornio Breakdown of academic impact, for papers by Mahfoud Assem Breakdown of academic impact, for papers by Kenji Otsubo Breakdown of academic impact, for papers by Jean-Pierre Flinois Breakdown of academic impact, for papers by Jin‐ding Huang Breakdown of academic impact, for papers by John A. Pieper
Rankless by CCL
2026